Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Replacement: Total Voting Rights

24 Apr 2024 07:00

RNS Number : 7691L
IDOX PLC
24 April 2024
 

24 April 2024

Idox plc

("Idox" or "Group" or "Company")

Correction - Exercise of Share Options and Total Voting Rights

The following amendment has been made to the "Exercise of Share Options & Total Voting Rights" announcement released 17 April 2024 at 12.43pm under RNS No. 0060L

The original announcement incorrectly stated that the figure to be used for both the total number of ordinary shares in issue following Admission and the total number of ordinary shares with voting rights in the Company was 457,771,879. The correct figure to be used for the total number of ordinary shares in issue following Admission will be 459,377,981. The correct figure to be used for the total number of ordinary shares with voting rights in the Company will be 459,377,981.

All other details remain unchanged. The full amended text is shown below.

Idox plc (AIM: IDOX) a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, announces that it has issued 77,000 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by employees under its Idox plc Long Term Incentive Plans.

An application has been made for the 77,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 22 April 2024.

The Company holds no ordinary shares in treasury. The total number of ordinary shares in issue following Admission will be 459,377,981. Therefore, the total number of ordinary shares with voting rights in the Company will be 459,377,981.

The above figure of 459,377,981 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

For further information please contact:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive

 

Anoop Kang, Chief Financial Officer

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

 

Adam Telling

 

 

MHP

+ 44 (0) 20 3128 8100

Reg Hoare

 idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRIJMPTMTITBRI
Date   Source Headline
30th Aug 20198:18 amRNSHolding(s) in Company
30th Aug 20198:16 amRNSHolding(s) in Company
30th Aug 20197:00 amRNSDirectors' Dealings & Holdings in Company
20th Aug 20199:20 amRNSHolding(s) in Company
9th Aug 20193:16 pmRNSCompletion of Acquisition of Tascomi Ltd
8th Aug 201910:56 amRNSHolding(s) in Company
6th Aug 20198:06 amRNSDirectors' Dealings & Holdings in Company
31st Jul 201910:30 amRNSFurther Details on the Fundraising
31st Jul 20197:00 amRNSProposed Fundraising via accelerated bookbuild
22nd Jul 20197:00 amRNSHalf-year Report
4th Apr 20194:17 pmRNSDirector/PDMR Share Dealing
3rd Apr 20197:00 amRNSBoard Change
29th Mar 20191:08 pmRNSResult of AGM
29th Mar 20197:00 amRNSAGM Trading Update & 2016 Prior Year Adjustment
22nd Mar 20197:00 amRNSDirectorate Change
18th Mar 20195:16 pmRNSOption Awards
12th Mar 20193:17 pmRNSDirector Dealings and Option Awards
7th Mar 20191:29 pmRNSPosting of Annual Report and Notice of AGM
21st Feb 20197:00 amRNSFinal Results for the year ended 31 October 2018
20th Feb 20192:13 pmRNSExercise of Share Options & Total Voting Rights
1st Feb 20198:20 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSExtension of Banking Facilities
22nd Jan 20198:24 amRNSHolding(s) in Company
7th Jan 20192:50 pmRNSBoard Change
27th Nov 20187:00 amRNSYear End Trading Update
22nd Nov 20187:00 amRNSDirectorate Change
19th Nov 20187:00 amRNSDirectorate Change
5th Nov 20187:00 amRNSDisposal of Digital division
31st Oct 20187:00 amRNSDirectorate Change
25th Oct 20183:23 pmRNSHolding(s) in Company
19th Oct 20185:01 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSAppointment of Chief Financial Officer
12th Sep 20183:46 pmRNSHolding(s) in Company
10th Sep 201811:22 amRNSExercise of Share Options & Total Voting Rights
10th Sep 201810:02 amRNSHolding(s) in Company
5th Sep 20187:00 amRNSExercise of Share Options & Total Voting Rights
30th Aug 20187:00 amRNSDirectorate Change
17th Aug 201811:30 amRNSHolding(s) in Company
31st Jul 20189:09 amRNSHolding(s) in Company
27th Jul 20182:21 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSHalf-year Report
13th Jul 201811:33 amRNSHolding(s) in Company
10th Jul 20185:16 pmRNSNotice of half year results
4th Jul 20182:37 pmRNSHolding(s) in Company
20th Jun 20187:00 amRNSChange of Auditor
8th Jun 20184:19 pmRNSHolding(s) in Company
1st Jun 20187:00 amRNSAppointment of Chief Executive
31st May 201812:48 pmRNSHolding(s) in Company
29th May 20187:48 amRNSDirectorate Change
29th May 20187:47 amRNSHalf Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.